Veran Medical Technologies

The American company Veran Medical develops the advanced medical devices for intervention pulmonology, including navigation systems and devices for diagnosis of peripheral lung cancer.

History

2020: Olympus purchased Veran Medical Technologies for $340 million

At the beginning of December, 2020 Olympus announced acquisition of Veran Medical Technologies (VMT) for $340 million. The buyer makes out the transaction through the subsidiary company - Olympus Corporation of the Americas (OCA). The transaction purpose for Olympus - to strengthen the positions in the industry of the medical equipment due to expansion of the division of therapeutic solutions, reported in the press release.

We are very glad to acquisition of VMT because its portfolio of devices will complement our range and will even more strengthen our positions in the field of respiratory medical devices, - the director of the international transactions and the CEO of OCA Nacho Abia noted. - The most important part of this transaction - the unique electromagnetic VMT navigation system, access to which will allow us to create in the future versatile and competitive a portfolio of respiratory devices on the basis of already patented products.

Olympus purchased Veran Medical Technologies for $340 million

In particular, Olympus intends to integrate the endoscopic technologies with the navigation products VMT and to develop the optimized diagnostic system of peripheral lung cancer. The Olympus company expects that acquisition of VMT immediately will begin to bring it an additional income in the market of the USA as its endoscopic technologies already take a leading place among the systems of a bronchoscopy.

We are proud of the fact that we could combine efforts with such company as Olympus, - the CEO of VMT Jason Pesterfield told. - Thanks to the strategy of Olympus our unique developments will become available all over the world once.[1]

Notes